Home›Companies›Biotech & Pharma›Efemoral Medical

Efemoral Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 16, 2023·Suggest an edit

About Efemoral Medical

Efemoral Medical is a private company based in Los Altos, California. It has reported $4,725,000 raised in three offerings on Form D since November 2018. Its chief executive is Christopher Haig.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 12, 2023Jun 16, 2023$525,000of $3.0M target2$262KSAFERule 506(b)Form D ↗
May 30, 2022Nov 28, 2022$3,190,000of $7.5M target15$212KEquityRule 506(b)Form D ↗
Nov 8, 2018Nov 16, 2018$1,010,000of $2.0M target20$50,500EquityRule 506(b)Form D ↗
Total, three offerings$4,725,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Efemoral Medical's Form D filed Jun 16, 2023.

CH
Christopher Haig
CEO
On every Form D that Efemoral Medical has filed: 3 filings, from Nov 16, 2018 to Jun 16, 2023.

Sources

  1. SECEfemoral Medical, Inc. filing history